Skip to main content
. 2019 Oct 16;14(10):e0223769. doi: 10.1371/journal.pone.0223769

Table 6. Costs (RMB) of standard treatments with original brand anti-diabetic medicines.

Originators Dosage per day
(mg)
Median price per mg Cost for a duration Day’s wages to pay for treatment for urban residents Day’s income to pay for treatment for rural residents
Public Private Public Private Public Private P* Public Private P*
Acarbose 150 0.049 0.035 220.5 157.5 4.99 3.57 0.09 10.11 7.22 0.09
Glibenclamide 5 / / / / / / / /
Gliclazide
(30 mg)
30 0.063 0.0533 56.7 47.97 1.28 1.09 2.60 2.20
Gliclazide (80 mg) 80 0.016 0.0131 38.4 31.44 0.87 0.71 1.76 1.44
Glimepiride 2 2.597 1.9334 155.82 116.004 3.53 2.63 7.15 5.32
Glipizide 5 0.556 0.5286 83.4 79.29 1.89 1.80 3.83 3.64
Metformin 1000 0.003 0.002 90 60 2.04 1.36 4.13 2.75
Pioglitazone 30 / / / / / / / /
Repaglinide 2 1.428 1.667 85.68 100.02 1.94 2.26 3.93 4.59
Mean 0.67 0.61 104.36 84.60 2.36 1.92 4.79 3.88

/: No value, the original brand medicines were not available.

*: paired t tests.